Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs GSK✓SelectedUSD · GSKWMB vs GSK performance historyLatest closeAs of-1.64%11/19
Stock and ETF performance explorer

WMB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+15.7%
GSK return
+5.3%
Excess return
+10.4%
Maximum drawdown
-18.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-1.6%-0.1%-1.9%
7D-4.8%-4.7%0.0%-5.6%
30D-6.0%-4.7%-1.3%-6.5%
3M-9.1%-8.8%-0.3%-9.6%
6M-15.5%-4.6%-10.9%-15.6%
YTD+12.4%+1.0%+11.4%+14.3%
1Y+15.7%+6.9%+8.8%+18.0%
All+15.7%+5.3%+10.4%+18.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling